Using the 2022 guidelines, 49.5% of pediatric kidney transplant recipients were identified as having hypertension, compared to 36.2% under the 2014 guidelines.
Do the 2022 pediatric ABPM guidelines identify a different prevalence of hypertension and better correlate with markers of cardiovascular risk compared to the 2014 guidelines in pediatric kidney transplant recipients?
The 2022 pediatric ABPM guidelines classify significantly more pediatric kidney transplant recipients as hypertensive compared to the 2014 guidelines, and this reclassification better aligns with markers of arterial stiffness.
Effect estimate: null (95% CI null)
Absolute Event Rate: 49.5% vs 36.2%
p-value: p=<0.001
Compared to the 2014 criteria, the 2022 guidelines identified a higher proportion of pediatric kidney transplant recipients with HTN and more effectively identified abnormalities in recipients with elevated AASI. Our findings indicate that 2022 guidelines are better aligned with markers of arterial stiffness and cardiovascular risk.
Balani et al. (Terça,) conduziram outro estudo em Hipertensão em receptores pediátricos de transplante renal (n=105). A Monitorização Ambulatorial da Pressão Arterial (MAPA) vs. diretrizes de 2014 para MAPA foi avaliada na detecção de hipertensão utilizando diretrizes de 2022 e 2014 para MAPA (nulo, 95% CI nulo, p=<0.001). Usando as diretrizes de 2022, 49,5% dos receptores pediátricos de transplante renal foram identificados como hipertensos, em comparação com 36,2% sob as diretrizes de 2014.